Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

IONS Ionis Pharmaceuticals

Watchlist
40.970
+0.470+1.16%
Close  02/07 16:00 ET
High
41.010
Open
40.470
Turnover
23.74M
Low
39.940
Pre Close
40.500
Volume
584.64K
Market Cap
5.82B
P/E(TTM)
585.29
52wk High
48.820
Shares
142.05M
P/E(Static)
Loss
52wk Low
29.676
Float Cap
5.75B
Bid/Ask %
0.00%
Historical High
86.582
Shs Float
140.45M
Volume Ratio
0.88
Historical Low
2.500
Dividend TTM
--
Div Yield TTM
--
P/B
9.79
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.42%
Amplitude
2.64%
Avg Price
40.604
Lot Size
1
Float Cap
5.75B
Bid/Ask %
0.00%
Historical High
86.582
Shs Float
140.45M
Volume Ratio
0.88
Historical Low
2.500
Dividend TTM
--
P/B
9.79
Dividend LFY
--
Turnover Ratio
0.42%
Amplitude
2.64%
Avg Price
40.604
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.
CEO: Dr. Brett P. Monia, PhD
Market: NASDAQ
Listing Date: 04/17/1991
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist